GCaMP6f drug
Evidence from:
primary |
all sources
Related entities (8)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| clozapine | regulates | GCaMP6f | — | 1 |
| clozapine-N-oxide | regulates | GCaMP6f | — | 1 |
| GCaMP6f | expressed_in | GABA | — | 1 |
| GCaMP6f | expressed_in | glutamatergic neurons | — | 1 |
| GCaMP6f | associated_with | induced neurons | — | 1 |
| GCaMP6f | biomarker_for | neuronal activity | — | 1 |
| GCaMP6f | expressed_in | neurons | — | 1 |
| KCl | regulates | GCaMP6f | — | 1 |
Mentioned in (2)
Papers in which this entity is mentioned.
- Alcohol reverses the effects of KCNJ6 (GIRK2) noncoding variants on excitability of human glutamatergic neurons. (2023)
- Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications. (2020)
Merged raw entities (3)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| gcamp6f | drug | 2 | 6 |
| gcamp6f calcium indicator | drug | — | — |
| pgp-cmv-gcamp6f | drug | — | — |